• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用生理盐水替代腹水来预防腹腔静脉分流术后凝血病。

Prevention of coagulopathy after placement of peritoneovenous shunt with replacement of ascitic fluid by normal saline solution.

作者信息

Biagini J R, Belghiti J, Fekete F

出版信息

Surg Gynecol Obstet. 1986 Oct;163(4):315-8.

PMID:3764636
Abstract

Consumptive coagulopathy may complicate the early postoperative course of peritoneovenous shunting and be responsible for diffuse bleeding or even death. Since this complications has been related to procoagulant substances in ascitic fluid getting access to the systemic circulation, it was demonstrated that the replacement of the ascitic fluid by normal saline solution during shunt insertion decreases the prevalence and severity of postoperative coagulopathy.

摘要

消耗性凝血病可能使腹腔静脉分流术后早期病程复杂化,并导致弥漫性出血甚至死亡。由于这种并发症与腹水中的促凝物质进入体循环有关,研究表明在分流置入过程中用生理盐水替代腹水可降低术后凝血病的发生率和严重程度。

相似文献

1
Prevention of coagulopathy after placement of peritoneovenous shunt with replacement of ascitic fluid by normal saline solution.通过用生理盐水替代腹水来预防腹腔静脉分流术后凝血病。
Surg Gynecol Obstet. 1986 Oct;163(4):315-8.
2
[Coagulant and procoagulant factors in ascitic fluid--about etiology DIC induced by ascitic fluid infusion (author's transl)].[腹水的凝血及促凝血因子——关于腹水输注所致弥散性血管内凝血的病因(作者译)]
Igaku Kenkyu. 1981 Oct;51(4):177-85.
3
Failure of ascitic fluid replacement for prevention of coagulopathy post peritoneovenous shunt. Case report.腹腔静脉分流术后腹水置换预防凝血障碍失败。病例报告。
Acta Chir Scand. 1990 Apr;156(4):337-40.
4
Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.腹腔静脉分流术的凝血病:腹水胶原蛋白致病作用及抗血小板治疗价值的研究
Gut. 1983 May;24(5):412-7. doi: 10.1136/gut.24.5.412.
5
Disseminated intravascular coagulation with the peritoneovenous shunt.
Ann Intern Med. 1979 May;90(5):774-6. doi: 10.7326/0003-4819-90-5-774.
6
Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
Aust N Z J Med. 1981 Feb;11(1):8-12.
7
Ascites-induced LeVeen shunt coagulopathy.腹水诱导的LeVeen分流术凝血障碍。
Ann Surg. 1983 Jul;198(1):91-5. doi: 10.1097/00000658-198307000-00018.
8
[Disseminated intravascular coagulation caused by re-infusion of ascitic fluid. Correlations between pro-aggregant and pro-coagulant factors of the ascitic fluid].[腹腔积液回输引起的弥散性血管内凝血。腹腔积液促聚集因子与促凝血因子之间的相关性]
Arch Maragliano Patol Clin. 1979;35:53-5.
9
Palliation of malignant ascites by the Denver peritoneovenous shunt.丹佛腹腔静脉分流术缓解恶性腹水
Ann R Coll Surg Engl. 1984 Sep;66(5):340-3.
10
[Treatment of hemorrhagic syndrome caused by peritoneovenous shunt with a flow regulation device].
G Chir. 1990 Jul-Aug;11(7-8):413-5.

引用本文的文献

1
Reinfusion of Malignant Ascites through an Extracorporeal Peritoneal Venous Shunt to Avoid Complications and Assess the Safety of a Denver Shunt: A Case Report.通过体外腹膜静脉分流术回输恶性腹水以避免并发症并评估丹佛分流术的安全性:一例报告
Case Rep Oncol. 2025 Feb 27;18(1):286-295. doi: 10.1159/000543892. eCollection 2025 Jan-Dec.
2
Role of surgical therapy in management of intractable ascites.手术治疗在顽固性腹水管理中的作用。
World J Surg. 1994 Mar-Apr;18(2):240-5. doi: 10.1007/BF00294408.
3
Herniorrhaphy and concomitant peritoneovenous shunting in cirrhotic patients with umbilical hernia.
肝硬化合并脐疝患者的疝修补术及同期腹膜静脉分流术
World J Surg. 1990 Mar-Apr;14(2):242-6. doi: 10.1007/BF01664882.